These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1652304)

  • 41. DNA content as a prognostic factor in endometrial carcinoma.
    Newbury R; Schuerch C; Goodspeed N; Fanning J; Glidewell O; Evans M
    Obstet Gynecol; 1990 Aug; 76(2):251-7. PubMed ID: 2371030
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical characteristics of prognostic factors in uterine endometrioid adenocarcinoma of various grade.
    Dvalishvili I; Charkviani L; Turashvili G; Burkadze G
    Georgian Med News; 2006 Mar; (132):24-7. PubMed ID: 16636372
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
    Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
    Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Cytological study on uterine sarcoma].
    Nakayama K; Kaku S; Chin Z; Yagi H; Hirai Y; Hamada T; Yamauchi K; Hasumi K; Masubuchi K
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Jan; 40(1):21-5. PubMed ID: 2832489
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Molecular carcinogenesis of ovarian carcinoma].
    Diebold J
    Verh Dtsch Ges Pathol; 2005; 89():77-83. PubMed ID: 18035676
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative clinicopathologic and immunohistochemical analysis of uterine sarcomas diagnosed using the World Health Organization classification system.
    D'Angelo E; Spagnoli LG; Prat J
    Hum Pathol; 2009 Nov; 40(11):1571-85. PubMed ID: 19540555
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cervicovaginal cytology in uterine adenocarcinoma and adenosquamous carcinoma. Comparison of cytologic and histologic findings.
    Costa MJ; Kenny MB; Naib ZM
    Acta Cytol; 1991; 35(1):127-34. PubMed ID: 1994621
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Carcinosarcoma of the uterus. Cytologic and ultrastructural features.
    Izumi S; Hasegawa T; Tsutsui F; Kurihara S
    Acta Cytol; 1985; 29(4):602-6. PubMed ID: 3861052
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: experience in Helsinki University Central Hospital 1990-2001.
    Koivisto-Korander R; Butzow R; Koivisto AM; Leminen A
    Gynecol Oncol; 2008 Oct; 111(1):74-81. PubMed ID: 18657852
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Endometrial stromal sarcoma and poorly differentiated endometrial sarcoma.
    Evans HL
    Cancer; 1982 Nov; 50(10):2170-82. PubMed ID: 7127257
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomas.
    McCluggage WG
    Int J Gynecol Cancer; 2002; 12(6):687-90. PubMed ID: 12445244
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus. A Gynecologic Oncology Group pathologic study of 203 cases.
    Silverberg SG; Major FJ; Blessing JA; Fetter B; Askin FB; Liao SY; Miller A
    Int J Gynecol Pathol; 1990; 9(1):1-19. PubMed ID: 2152890
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Uterine tumors of mesenchymatous origin: problem of their definition and classification].
    Van Bogaert LJ; Maldague P
    Arch Anat Pathol (Paris); 1975; 23(3):185-92. PubMed ID: 174493
    [No Abstract]   [Full Text] [Related]  

  • 54. [Carcinosarcomas (malignant mixed Mullerian tumors) of the uterus. Morphology, pathogenetic aspects and prognostic factors].
    Horn LC; Dallacker M; Bilek K
    Pathologe; 2009 Jul; 30(4):292-301. PubMed ID: 19495763
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pathologic and molecular features of uterine carcinosarcomas.
    Lopez-Garcia MA; Palacios J
    Semin Diagn Pathol; 2010 Nov; 27(4):274-86. PubMed ID: 21309261
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Uterine carcinosarcoma: A review of the literature.
    Cantrell LA; Blank SV; Duska LR
    Gynecol Oncol; 2015 Jun; 137(3):581-8. PubMed ID: 25805398
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Long-term study of endometrial cell sampling and cytologic evaluation with special reference to Prevical and Curity].
    Caniels B; Hammans W; Landowski J
    Geburtshilfe Frauenheilkd; 1985 Dec; 45(12):853-9. PubMed ID: 4085760
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cervicovaginal cytology in carcinosarcoma [malignant mixed mullerian (mesodermal) tumor] of the uterus.
    Costa MJ; Tidd C; Willis D
    Diagn Cytopathol; 1992; 8(1):33-40. PubMed ID: 1312925
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cyclooxygenase-2 expression in malignant mesenchymal tumors and related uterine lesions.
    Matsumoto Y; Ishiko O; Sumi T; Yoshida H; Deguchi M; Nakagawa E; Haba T; Wakasa K; Ogita S; Ando Y
    Oncol Rep; 2001; 8(6):1225-7. PubMed ID: 11605037
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The immunohistochemical profile of malignant mixed müllerian tumor. Overlap with endometrial adenocarcinoma.
    Meis JM; Lawrence WD
    Am J Clin Pathol; 1990 Jul; 94(1):1-7. PubMed ID: 1694389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.